Publications by the researcher in collaboration with Francisca Lago Paz (37)

2022

  1. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway

    Cartilage, Vol. 13, Núm. 2, pp. 925S-934S

2019

  1. Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil

    Journal of Agricultural and Food Chemistry, Vol. 67, Núm. 14, pp. 3845-3853

2018

  1. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways

    Cellular Physiology and Biochemistry, Vol. 49, Núm. 6, pp. 2414-2426

2017

  1. Leptin in the interplay of inflammation, metabolism and immune system disorders

    Nature Reviews Rheumatology, Vol. 13, Núm. 2, pp. 100-109

  2. Progranulin as a biomarker and potential therapeutic agent

    Drug Discovery Today, Vol. 22, Núm. 10, pp. 1557-1564

2016

  1. E74-like factor 3 and nuclear factor-κB regulate lipocalin-2 expression in chondrocytes

    Journal of Physiology, Vol. 594, Núm. 21, pp. 6133-6146

  2. Pollutants make rheumatic diseases worse: Facts on polychlorinated biphenyls (PCBs) exposure and rheumatic diseases

    Life Sciences, Vol. 157, pp. 140-144

  3. The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1

    Scientific Reports, Vol. 6

2015

  1. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  2. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  3. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases

    Biomarkers, Vol. 20, Núm. 8, pp. 565-571

2014

  1. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

  2. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

  3. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  4. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases

  5. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes

    Journal of Orthopaedic Research, Vol. 32, Núm. 9, pp. 1137-1146

  6. NUCB2/nesfatin-1: A new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study

    Journal of Orthopaedic Research, Vol. 32, Núm. 5, pp. 653-660

2013

  1. Adipokines, molecular players at the crossroad between inflammation and oxidative stress: Role in arthropathies

    Studies on Arthritis and Joint Disorders (Springer New York), pp. 67-88

  2. Adipokines: Novel players in rheumatic diseases

    Discovery Medicine, Vol. 15, Núm. 81, pp. 73-83